News & Events
Better samples, better science: new study explores integrity of research specimens
September 23, 2019
Effective diagnosis and treatment of disease draws on painstaking research, which often relies on biological samples. The avalanche of studies used to better understand illnesses and design effective therapies cost billions of dollars and potentially affects millions of lives. So, it would seem reasonable to assume that the reliability of biological samples, on which accurate results depend, would be of paramount concern for the scientific community. According to Chad Borges, a researcher...
Early indicators of lung cancer probed in new study
May 29, 2013
Many of the critical processes underlying cancer formation and eventual metastasis to other organs remain mysterious. In the quest for earlier diagnoses and more effective treatment, intensive research efforts have been applied to the search for biomarkers—presymptomatic signs of disease detectable in blood, saliva, or other biofluids. Chad Borges, an analytical biochemist working at Arizona State University’s Biodesign Institute has been studying a particularly promising class of...
ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment
November 1, 2011
Arizona State University will lead a four-year, $5 million expanded initiative sponsored by the National Institutes of Health to discover proteins, or biomarkers, to help predict cardiovascular disease and to assess potential new treatments in people with type 2 diabetes. Nearly 26 million Americans have diabetes, the seventh leading cause of death in the U.S. The disease is a major cause of heart disease, stroke, kidney disease, blindness and amputation. The national cost of diabetes was an...